Diligence memo · auto-generated · as of July 2, 2026
Prescribe FIT, Inc.
Prescribe FIT, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Prescribe FIT, Inc. operates in Other Health Care, based in COLUMBUS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Prescribe FIT, Inc. has raised $7.1M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.1M on 2023-04-19.
Most recent recorded round closed around 2025-10-16.
Valuation (modeled)modeled
Provath models Prescribe FIT, Inc. at approximately $382K (range $127K–$718K). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.09× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 9 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 6.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 70% of Other Health Care peers (5377 compared).
Modeled value ranks above 2% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.